• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,362
2,297
1,863
1,845
1,724

COUNTRY

872
646
269
253
211

CATEGORIES

  • 858
  • 187
  • 678
  • 1,126
    • 99
  • 389
  • 270
  • 252
  • 65
  • 378
  • 682
  • 1,319
  • 1,354
  • 625
  • 883
  • 1,690
  • 2,670
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 507
  • 730
  • 0
  • 93

PRICE

6,795
11,417
17,892
25,085

PUBLISHED

1,959
2,804
7,340
25,085

PRODUCT TYPE

20,964
2,901
870
164
74
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Bactolac Pharmaceutical, Inc.,(BTCA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Bactolac Pharmaceutical, Inc.,(BTCA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Bactolac Pharmaceutical, Inc.,(BTCA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Bactolac Pharmaceutical, Inc. (BTCA), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
International Stem Cell,(ISCO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages International Stem Cell,(ISCO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

International Stem Cell,(ISCO) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for International Stem Cell (ISCO), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Interpharm Holdings, Inc.,(IPAH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Interpharm Holdings, Inc.,(IPAH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Interpharm Holdings, Inc.,(IPAH) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Interpharm Holdings, Inc. (IPAH), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Lorus Therapeutics Inc,(LRUSF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Lorus Therapeutics Inc,(LRUSF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Lorus Therapeutics Inc,(LRUSF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Lorus Therapeutics Inc (LRUSF), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Luminex Corporation,(LMNX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Luminex Corporation,(LMNX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Luminex Corporation,(LMNX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Luminex Corporation (LMNX), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Luye Pharma Group Ltd,(LUYEF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Luye Pharma Group Ltd,(LUYEF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Luye Pharma Group Ltd,(LUYEF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Luye Pharma Group Ltd (LUYEF), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Puma Biotechnology Inc,(PBYI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Puma Biotechnology Inc,(PBYI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Puma Biotechnology Inc,(PBYI) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Puma Biotechnology Inc (PBYI), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
QIAGEN NV,(QGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages QIAGEN NV,(QGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

QIAGEN NV,(QGEN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for QIAGEN NV (QGEN), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
TG Therapeutics Inc,(TGTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages TG Therapeutics Inc,(TGTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

TG Therapeutics Inc,(TGTX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for TG Therapeutics Inc (TGTX), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
TheraBiogen, Inc.,(TRAB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages TheraBiogen, Inc.,(TRAB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

TheraBiogen, Inc.,(TRAB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for TheraBiogen, Inc. (TRAB), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Disease and Therapy Review: Migraine Disease and Therapy Review: Migraine - Product Thumbnail Image

Disease and Therapy Review: Migraine

The Migraine Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and...

October 2013
FROM

Global RNAi Drug Pipeline Analysis

Global RNAi Drug Pipeline Analysis” gives a comprehensive insight on the various drugs being developed based upon RNAi technology Research report covers all the ongoing drugs being developed in various...

October 2013
FROM

Global Infertility Drug Pipeline Analysis

The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques The...

October 2013
FROM
Colorectal Cancer - KOL Insight Module Colorectal Cancer - KOL Insight Module - Product Thumbnail Image

Colorectal Cancer - KOL Insight Module

The global market for colorectal cancer (CRC) drugs is undergoing a fundamental shift due to wider generic competition in cytotoxics and increasing adoption of anti-EGFR products as first line therapies...

October 2013
FROM

Company Snapshot – AstraZeneca Pharma India Limited

This company snapshot provides an overall assessment of the company and its progress It describes management type and share holding pattern, categories of businesses and subsidiaries, financial and...

October 2013
FROM

Pharmaceutical Companies Directory - USA

This is a directory of 1,333 professionals in U S Pharmaceutical companies in Microsoft Excel format It is searchable, and exportable for use in mailings and lead generation This database includes the...

October 2013
FROM
Physician Views: Life Beyond Statins – What Opportunity for PCSK9 Inhibitors? Physician Views: Life Beyond Statins – What Opportunity for PCSK9 Inhibitors? - Product Thumbnail Image

Physician Views: Life Beyond Statins – What Opportunity for PCSK9 Inhibitors?

With Sanofi and Regeneron Pharmaceuticals set to unveil the first Phase III data for their experimental PCSK9 inhibitor alirocumab imminently, expectation for this class of therapies is set to rise...

October 2013

Global HIV Infection Drug Pipeline Analysis

The discovery of HIV virus, which causes AIDS, dates back to more than 30 years Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection...

October 2013
FROM

Global DNA Vaccine Pipeline Analysis

The global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena...

October 2013
FROM

Europe Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos